Radiation & EnvironmentIrradiation & DevelopmentSafety & Power

Current situation at NRG

On Thursday May 15th, the television documentary KRO Brandpunt Reporter paid attention to the development of the new PALLAS reactor and the financial situation at NRG. The program reported that NRG has applied for a bridging loan from the Ministry of Economic Affairs.

The Ministry is currently considering this request and the conditions under which a credit could be provided. The Minister has indicated that he wishes to take a positive decision, but that this must be a good decision. Before he can make that decision, he requires more information from NRG.

There is as yet no question of a liquidity problem at NRG. The activities will continue and all nuclear installations are in operation.

NRG is the world leader in the production of medical isotopes. Every day these isotopes are used for diagnoses and pain (cancer) therapy for 24,000 patients worldwide. In the Netherlands 1,300 patients daily rely on these isotopes. Over the past year NRG suffered a substantial loss as a result of the prolonged shutdown of the High Flux Reactor. To operate the reactor - which is reaching the end of its economic life – in a  safe and reliable way until the commissioning of the new PALLAS reactor, a number of investments will have to be made.

Based on long-term agreements that NRG has recently made with the major customers of her reactor, these investments can be earned back in the long term and the bridging loan will be repaid.